Share this
Blog
Huma's attendance at the BIO International Convention, Boston on June 5th, 2023
June 1, 2023
Blog
Huma's attendance at the BIO International Convention, Boston on June 5th, 2023
June 1, 2023
Share this
Huma is excited to announce our attendance at the upcoming BIO International Convention, one of the most prestigious biotechnology and life sciences events. We look forward to connecting with industry professionals, sharing our innovations, and exploring collaborations that can shape the future of healthcare.
The BIO International Convention will be held from June 5 to June 8, 2023, at the Boston Convention & Exhibition Center in Boston, MA.
We will have two senior executives, from our Software as a Medical Device (SaMD) pharma team (profiles below), attending the event. Reach out to them, via the form below, or the Bio event app and discover more about our recently announced EU MDR Class IIb award and what it means for the future of patient-centred care & the pharmaceutical industry. Tim and Paul can also provide insights into the innovation behind our latest collaborations with UCB, Bayer, and AstraZeneca, and how our regulated platform can help drive your pharmaceutical goals and objectives.
If you would like to schedule a meeting with our team, please contact us by filling in the form below.
Paul Schultz, VP Global Pharma Partnerships
Paul has over 15 years of experience across pharma, medtech and digital health. Over the past five years, Paul has focused on partnering with large pharma to identify key pain points along the patient journey that can be solved through innovative Software as a Medical Device (SaMD) solutions while also driving brand value at scale.
Tim Broke-Smith, VP Global Pharma Partnerships
Tim Broke-Smith is a senior commercial, operations and BD executive with over 15 years experience building international partnerships in life sciences. Tim is passionate about creating solutions for pressing healthcare problems through innovation and collaboration across digital health, biotech and pharma. Currently VP Global Pharma Partnerships at Huma Therapeutics, Tim previously held CBO/COO roles in clinical stage biotech companies. Tim has a wealth of experience across product and business development and corporate governance. Tim holds a Master’s in Bioscience Enterprise from Cambridge University and Bachelor’s in Biology from Imperial College London.
Thank you for your request.
You will receive an email from us shortly containing the file. Please check your inbox (and promotions tab or spam folder, if necessary) for the email.
Oops! Something went wrong while submitting the form
Making an impact
3000+
3000+ hospitals and clinics supported across Huma platforms to secure the most sustainable impact for patients1
×2
Our platform can almost double clinical capacity and reduce readmission rates by >30%3
27m+
Huma's digital-first health platforms support a network of 27m patients1
1m+
Over 1 million devices have been shipped in support of our projects and we know what it takes to deploy at scale1
Winner of the 2022 Prix Galien award for digital health, widely regarded as 'pharma's Nobel prize'4
Selected as one of 'The Most Important Healthcare Design of 2021' by Fast Company5
Winner of the 2022 Prix Galien award for digital health, widely regarded as 'pharma's Nobel prize'4
Winner of the 2022 Prix Galien award for digital health, widely regarded as 'pharma's Nobel prize'4
Sources:
Blog
Huma's attendance at the BIO International Convention, Boston on June 5th, 2023
June 1, 2023
Blog
Huma's attendance at the BIO International Convention, Boston on June 5th, 2023
June 1, 2023
Huma joins digital pioneers to advance health equity in care and research
Chief Executive Officer and Founder, Dan Vahdat, is returning to the annual World Economic Forum’s main conference where he will join a panel discussion devoted to improving care for non-communicable disease and tackling health equity. Accompanied by Chief Financial and Strategy Officer, Ingeborg Oie, Dan is looking forward to connecting with other attendees to explore how Huma’s digital health platform can make healthcare more equitable, and advances proactive, predictive care.
Huma joins digital pioneers to advance health equity in care and research
Date:Wednesday, January 18, 2023
Time:4:15 - 5:15 p.m. CET
Location:Ice Village, Eisbahnstrasse 5, Davos, Switzerland
Dan will join the Digital Health Action Alliance panel at Davos to discuss Turning the Tide in Non-Communicable Disease Care Through Digital Health and Community Connection. Huma has a long history of advancing the care of non-communicable diseases (NCDs) such as heart disease, cancer, diabetes and lung conditions. Huma’s innovative remote patient monitoring platform enables broad patient recruitment, reduces reliance on in-person clinic visits and increases health system efficiency.
*This session is open to registered Annual Meeting 2023 participants and Affiliate badge holders.
Huma is one of the first to sign the Zero Health Gaps Pledge
Huma is one of the first signatories to the Zero Health Gaps Pledge, the World Economic Forum’s Global Health Equity Network’s (GHEN) initiative. Huma supports GHEN’s ambition to build a future without disparities in health or wellbeing outcomes. Huma’s digital platform has been built on a deep clinical knowledge of complex patient needs and how people engage with technology and we are committed to ensuring our technology promotes health equity. We are proud to work with governments, hospital groups, universities, life science and technology companies to bring greater scale and impact and help all people live longer, fuller lives.
Huma at World Economic Forum
Global Innovators and Tech Pioneers
Dec 2022: Huma selected to join 100 innovative companies on a two-year journey as part of the World Economic Forum’s initiatives, activities and events, bringing their cutting-edge insight and fresh thinking to critical global discussions.
Learn more
Working Together, Restoring Trust
May 2022: With the aim to address economic, environmental, political, and social fault-lines exacerbated by the COVID-19 pandemic, Dan Vahdat speaks at WEF annual meeting about the importance of scientific collaboration.
Learn more
Accelerating innovation and breaking new ground
October 2022: Dan joined the WEF Biotech Future Forum 2022 to discuss how start-ups are breaking new ground in biotech and changing the way we interact with the world, but also how the sector can earn trust, scale successfully and spot the brightest innovations.
Learn more
Making connections at Davos
Jan 2019: Dan attended WEF as an unofficial attendee and spoke to CNBC about the importance of meeting in-person to make connections.
Learn more
